Pharmaceutical

Why is the healthcare industry hesitant to join the met...

The Covid-19 pandemic pushed the healthcare industry toward rapid digitalisation...

Abbisko tenosynovial giant cell tumour therapy gains fa...

Abbisko Therapeutics has received fast track designation from the US FDA for pim...

Amgen receives FDA priority review for tarlatamab BLA

Amgen has received US FDA priority review for its biologics licence application ...

Acadia victorious in court for Parkinson’s drug Nuplazi...

Acadia received two patent rulings that strengthen Nuplazid’s patent position an...

Pharma readies for climate disasters amidst supply chai...

Experts discussed the potential impacts of climate change on the pharma supply c...

Novo Nordisk acquires Alkermes’s Irish plant to expand ...

Novo Nordisk will pay $92.5m in one-time cash payment to Alkermes, and the deal ...

Mission Therapeutics forges ahead with Phase II study f...

A Phase II clinical trial treating 160 acute kidney injury patients with MTX652 ...

Eight evolving patient communication risks in pharma an...

In this article, we’ll explore the patient communication risks that now confront...

Opinion: Listen: When do tests hurt more than help?

When is a diagnostic test for a rare disease worth taking?

Opinion: Sobering centers offer a safe place to recover...

Sobering centers offer a safe place to recover from intoxication. Every communit...

Gene therapy offered this 7-year-old freedom. The price...

For a 7-year-old girl, a gene therapy for beta thalassemia offered freedom. The ...

Doctors call out ableism in cancer care: ‘The biggest a...

Doctors' assumptions about patients with disabilities can undermine cancer care ...

STAT+: Could sickle cell someday be treated not with CR...

Novartis unveiled early animal data suggesting that they might have a promising ...

STAT+: Humana used algorithm in ‘fraudulent scheme’ to ...

Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit allegin...

STAT+: Maze CEO ‘personally disappointed’ in Sanofi dec...

The CEO of Maze Therapeutics said he learned Sanofi would end its partnership wi...

STAT+: A targeted therapy shows it can offer a ‘last, g...

A new type of targeted therapy enabled a leukemia patient to "see my dog, hang o...